The company, which has been pushing its IPO plans for the past year, has been waiting to complete the integration of its acquired biosimilars firm Viatris and refinance debt before it goes public ...

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

Dr Agarwal IPO opened for subscription on January 29 and will end today, January 31 The IPO price band is set at ₹382 to ₹402 ...

The startup plans to raise $400 Mn to $500 Mn through the public issue at a valuation of $1.5 Bn, sources told Inc42.

Sebi is proposing a new combo product that pairs term life insurance with mutual fund investments, aiming to expand financial access and boost SIPs, particularly in rural areas.

Dr Agarwal's Healthcare will utilise ₹195 crore out of the net fresh issue proceeds for repaying its debt, and the remaining ...

Dr Agarwal's Health Care IPO received 1.55 times subscription on the final day, with QIBs showing strong interest. The Rs ...

Metsera and Maze Therapeutics have become the second and third biotechs to complete an initial public offering (IPO) on the ...

Demand from investors covered all the shares offered by Hotelbeds owner HBX Group in its initial public offering within hours ...

Captain Fresh, a B2B seafood startup, raised Rs 250 crore in pre-IPO funding, bolstering its financial base. With these funds, it aims to achieve USD 1 billion in revenue and bolster its market ...

The digital health unicorn sells its chronic condition management and musculoskeletal programs to employers and health plans ...

NMDC Energy PJSC, a key player under the NMDC Group umbrella, has announced exceptional financial results for 2024, marking a ...